Health and Biomedical Sciences
22Health Ventures
22Health Ventures is an early-stage venture firm, embedded in Singapore and including a venture fund providing capital to innovative healthtech entrepreneurs, alongside a value-add services platform supporting Singapore’s healthtech innovation ecosystem to help startups become globally competitive.
Advanced MedTech Holdings
Advanced MedTech Holdings (AMTH) is a global medical technology leader with a core focus in urology devices and contract manufacturing services. AMTH makes strategic investments in disruptive medical technology companies, strengthening its portfolio of healthcare solutions for customers worldwide.
Altara Ventures
Altara is a Series A stage venture capital firm headquartered in Singapore and focused on technology investments across Southeast Asia.
ClavystBio
ClavystBio’s mission is to accelerate the commercialization of life sciences breakthroughs into human health impact. They invest and partner with innovators, entrepreneurs and founders to launch and grow global companies in Singapore
Coronet Ventures
Coronet Ventures Singapore-based venture unit of Cedars-Sinai Medical Centre. Coronet Ventures is interested in early-stage healthcare and biomedical science startups.
East Ventures
East Ventures is a pioneering and leading sector-agnostic venture capital firm in Southeast Asia. Founded in 2009, East Ventures has transformed into a holistic platform that provides multi-stage investment, from Seed to Growth stage investments, for over 300 tech companies across Southeast Asia.
EVX Ventures
EVX Ventures is a global VC with offices across Singapore, Shanghai & Boston, that builds, incubates, and invests in biotech companies. With a focus on disruptive therapeutics platform technologies and novel therapeutic modalities, we invest to redefine the therapeutics of tomorrow.
HealthXCapital
HealthXCapital is an early stage investment platform providing smart, connected capital to healthcare startups focused on emerging markets in South East Asia and India.
Heritas Capital
Heritas Capital is a Singapore-based private equity and venture capital investment firm, building a multi-fund impact investment platform that backs innovative companies from seed to growth stages across the healthcare, education, food, environment, and technology sectors in Asia.
Kurma Partners
Kurma Partners finances innovation to build the healthcare industry of tomorrow. Kurma invests from company inception to growth in biotechnology, digital health and diagnostics and others. Based in Paris and Munich with global reach, Kurma contributes to innovation ecosystems in Europe and beyond.
Lightstone Singapore
Lightstone invests in early-stage, therapeutic-oriented, life science companies. Their goal is to find breakthrough therapies that have the potential to change the practice of medicine and they are committed to seeking out novel, disruptive and defensible technologies to meet unmet clinical needs.
MassMutual Ventures
MassMutual Ventures is a multistage global venture capital firm with teams based in Singapore, London and Boston, managing over $1 billion in investment capital. The fund’s investment focus is on fintech, digital health, enterprise SaaS, climate SaaS, and web3 and crypto infrastructure.
Monk's Hill Ventures
Mong's Hill Ventures is a venture capital firm investing in early-stage tech companies, primarily pre-Series A and Series A, in Southeast Asia. Backed by institutional investors and family offices worldwide, MHV works with great entrepreneurs to use technology to improve the lives of millions of people.
NSG Ventures
NSG Ventures is a global biotech venture capital firm started and managed by scientific experts, seasoned operators, investors, and drug development professionals of successful biotech companies. Their investment focus is to back and build early-stage transformative drug discovery companies globally.
Pix Vine Capital
Pix Vine Capital is a Singapore-based Investment House providing early-stage venture capital to startups aspiring to commercialize innovative deep tech solutions in the areas of Services & Digital Economy, Web3, and Healthcare & Bio-Medical Sciences.
Pureland Venture
Pureland's mission is to bring medical access and saving to 100M people globally. They look for companies which can inject value into the patient caring system, save lives and reduce supply-demand gap in healthcare systems. They have portfolio companies invested in US, Europe, India and ASEAN..jpg)
Temasek Life Sciences Accelerator
Temasek Life Sciences Accelerator (TLA), a joint venture between Temasek Life Sciences Laboratory (TLL) and Vertex Holdings (VH), aims to incubate, nurture and grow disruptive life science innovations into early stage companies, with the vision of becoming tomorrow’s champion.
Trendlines Medical Singapore
Trendlines Medical Singapore, a subsidiary of The Trendlines Group (SGX: 42T; OTCQX: TRNLY), is a medical technology start-up incubator established in 2016. The incubator invents, discovers, invests in, and incubates innovative medical technologies companies to improve the human condition.
Trinity Innovation Bioventure Singapore
TIBS is a Singapore-based VC specialising in early-stage biotech investment globally. As an investor, we support passionate scientists and entrepreneurs in transforming cutting-edge scientific research into successful ventures. We have invested over $300m in over 30 portfolio companies across Asia.
Valuence Ventures
Valuence Ventures is a U.S.-based VC firm dedicated to advancing the growth of companies pioneering deeptech innovations. With a strategic focus on the cleantech and biotech sectors, Valuence Ventures is committed to fostering deeptech’s transformative role in enhancing planetary and human health.
Verge HealthTech Fund
Verge HealthTech Fund invests globally and exclusively into impactful health technology startups at their earliest stages. Their team has invested in 46 healthtech startups across 20 countries, impacting over 40 million lives.
Vickers Venture Partners
Vickers Venture Partners is a Deep Tech VC firm investing in key enabling technologies in AI, Biotechnology, and Sustainability to address urgent global problems. With strong in-house expertise, we drive growth in Southeast Asia, USA, China and Europe, achieving 21 successful exits globally.